<DOC>
	<DOCNO>NCT00512356</DOCNO>
	<brief_summary>The objective study evaluate efficacy Anti-Adhesion Product ( AAP ) prevent reduce post-operative adhesion formation re-formation subject population abdominal surgery leave rectal stump temporary stoma first procedure schedule laparoscopy/ laparotomy second procedure normal treatment subject ' disease . In study group , surgical measure prevent adhesion take , e.g . use minimum traumatizing surgical technique , use powder-free glove . In investigational product group , AAP apply rectal stump incision line specific additional treatment apply control group . The surgeon assess preexist adhesion first surgery . Newly develop re-formed adhesion evaluate second surgery surgeon assistant know result randomization . The safety study drug also monitor .</brief_summary>
	<brief_title>Efficacy Safety Study Anti-Adhesion Product Prevention Intraperitoneal Adhesions</brief_title>
	<detailed_description />
	<mesh_term>Tissue Adhesions</mesh_term>
	<criteria>Written inform consent obtain subject subject 's legally authorize representative prior study entry Male female subject &gt; 18 year age Subjects undergoing abdominal surgery possibility rectal stump would remain due one follow reason : inflammatory bowel disease , neoplasm , colon diverticulitis , colonic obstruction , colon polyposis , peritoneal trauma , fistula , incontinence , reason Subjects second abdominal surgery plan within approximately eight month first surgical procedure . Pre operative : Pregnancy lactation period Subjects concurrently participate another clinical trial drug device Subjects participate clinical trial drug device within 30 day prior study Subjects abdominal/pelvic surgery within six month prior study Subjects receive receive ( approximately within next eight month ) abdominal/pelvic irradiation Intra operative : Subjects peritonitis Subjects gastrointestinal metastatic cancer , cancer grow per continuitatem surround tissue Subjects treat hemostatic agent ( e.g . fibrin sealant , collagen , oxidize cellulose ) first surgery Subjects treat adhesion prevention agent AntiAdhesion Product ( AAP ) ( e.g . Intergel® Adhesion Prevention Solution , Seprafilm® Membrane ) first surgery Subjects major fecal contamination need abdominal lavage first surgery</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2007</verification_date>
</DOC>